Schedule Update - effective 1 January 2009 (text extract)

This is the text extract for Schedule Update - effective 1 January 2009, browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 January 2009 Section H cumulative for December 2008 and January 2009

Contents

Summary of PHARMAC decisions effective 1 January 2009 ........................... 3 Named Specialists for antiretrovirals ............................................................. 4 Panadol – price increase ................................................................................ 5 Omeprazole – subsidy changes ..................................................................... 5 Scopoderm TTS ............................................................................................. 6 Levothyroxine stock shortages ...................................................................... 6 Changes to the available presentations of diltiazem hydrochloride............... 7 Tender News .................................................................................................. 8 Looking Forward ........................................................................................... 8 Sole Subsidised Supply products cumulative to January 2009 ....................... 9 New Listings ................................................................................................ 18 Changes to Restrictions ............................................................................... 19 Changes to Subsidy and Manufacturer’s Price............................................. 20 Changes to Description ............................................................................... 23 Changes to Sole Subsidised Supply ............................................................. 23 Delisted Items ............................................................................................. 24 Items to be Delisted .................................................................................... 25 Section H changes to Part II ........................................................................ 30 Section H changes to Part IV ....................................................................... 32 Index ........................................................................................................... 33

Summary of PharmaC decisions

effeCtIve 1 JaNuary 2009 New listings (page xx) • Allopurinol (Apo-Allopurinol) tabs 100 mg and 300 mg • Italian long style spaghetti (Orgran) 220 g dried pasta • Clozapine (Clopine) oral liq 50 mg per ml, 100 ml Changes to restrictions (pages xx to xx) • Magnesium hydroxide mixture Decreased subsidy (page xx) • Amoxycillin (Amoxil Paediatric Drops) oral liquid 125 mg per 1.25 ml • Amoxycillin (Ibiamox) inj 250 mg, 500 mg and 1 g • Aqueous (Multichem) crm 500 g • Ciprofloxacin (Cipflox) tab 250 mg, 500 mg and 750 mg • Citalopram (Celapram, Citalopram-Rex and Arrow-Citalopram) tab 20 mg 28tab pack • Clotrimazole (Clotrimaderm 2%) 25 g vaginal crm 2% with applicators • Clozapine (Clopine) tab 25 mg, 50 mg, 100 mg and 200 mg • Clozapine (Clozaril) tab 25 mg and 100 mg • Nifedipine (Arrow-Nifedipine XR and Adefin XL) tab long-acting 30 mg and 60 mg • Octreotide (Sandostatin) inj 50 mcg per ml, 100 mcg per ml and 500 mcg per ml • Omeprazole (Losec) cap 10 mg, 20 mg and 40 mg • Oxaliplatin (Eloxatin) inj 50 mg, 100 mg and 1 mg for ECP • Polyvinyl alcohol (Liquifilm Tears) eye drops 1.4 % and (Liquifilm Forte) eye drops 3% Increased subsidy (page xx) • Hyoscine (Scopolamine) (Scopoderm TTS) patches 1.5 mg • Hypromellose (Methopt) eye drops 0.5% • Metoclopramide hydrochloride with paracetamol (Paramax) tab 5 mg with 500 mg paracetamol • Pyridostigmine (Mestinon) tab 60 mg

4 Pharmaceutical Schedule - Update News

Named Specialists for antiretrovirals

Below is a list of currently approved named Specialists that the Ministry of Heath has approved to prescribe HIV antiretroviral agents in New Zealand. Auckland Dr Rod Ellis-Pegler Dr Rick Franklin Dr David Holland Dr Joan Ingram Prof. Diana Lennon Dr Sally Roberts Dr Simon Rowley Dr Mark Thomas Dr Leslie Voss Dr Liz Wilson Dr Simon Briggs Dr Nicky Perkins Dr Stephen Ritchie Dr Mitzi Nisbet Palmerston North Dr Anne Robertson Wellington Dr Tim Blackmore Dr Nigel Raymond Dr Richard Steele Nelson Dr Richard Everts

Hamilton Dr Graeme Mills Dr Jane Morgan Christchurch Dr Stephen Chambers Dr Maud Meates-Dennis Dr Alan Pithie Dr Sarah Metcalf Tauranga Dr Katherine Grimwade Dunedin Dr Deborah Williams Napier Dr Richard Meech Dr Andrew Burns

Pharmaceutical Schedule - Update News

Panadol – price increase

A significant price increase on the Panadol brand of paracetamol from $1.38 to $14.67 per 150 tablets (ex-manufacturer, excluding GST) will take effect from 1 January 2009. This means that between 1 January 2009 and 30 April 2009 a manufacturer’s surcharge will apply to the Panadol brand of paracetamol. From 1 May 2009 the Panadol brand will be delisted from the Pharmaceutical Schedule. The Pharmacare brand of paracetamol tablet has been available fully subsidised since 1 December 2008 and will be the sole subsidised brand of paracetamol from 1 May 2009. The tender agreement for Pharmacare paracetamol will prevent a cost of approximately $20 million (in the next financial year) to the Pharmaceutical Budget that would result from continuing to fully subsidise Panadol at the increased price. Patient information leaflets have been sent to medical practitioners and pharmacies to help assist with explaining this change to patients. To order more patient leaflets please contact PHARMAC on 0800 11 22 37 or Marketing Impact by fax on 0800 455 442

Omeprazole – subsidy changes

As a result of the transition to sole supply of omeprazole (Dr Reddy’s Omeprazole) the following changes will take effect from 1 January 2009: • the subsidy for the Omezol brand of omeprazole will be removed and this brand delisted from the Pharmaceutical Schedule;

Pack size and strength 30 x 10 mg Brand (Supplier) Dr Reddy’s Omeprazole (Affordable Healthcare) Losec (AstraZeneca) Dr Reddy’s Omeprazole (Affordable Healthcare) Losec (AstraZeneca) Dr Reddy’s Omeprazole (Affordable Healthcare) Losec (AstraZeneca)

• the subsidy for the Losec brand of omeprazole will be reduced to match the same subsidy for the Dr Reddy’s brand of omeprazole 10 mg, 20 mg and 40 mg capsules; and • the ex manufacturer’s price for Losec is being reduced and part charges will apply as per the table below.

New Subsidy $2.14 $2.14 $3.05 $3.05 $3.59 $3.59 New Price $2.14 $8.43 $3.05 $9.00 $3.59 $11.25 Estimated Patient Part Charge* $0, Fully Funded $11.70 $0, Fully Funded $11.07 $0, Fully Funded $14.25

Current Subsidy and Price $2.14 $17.37 $3.05 $24.81 $3.59 $29.05

30 x 20 mg

30 x 40 mg

Note: All prices are ex. manufacturers and ex GST. * Manufacturers’ surcharge to patient estimation = (price - subsidy) x 1.86

The listing of the Dr Reddy’s Omeprazole infusion in Section H of the Pharmaceutical Schedule will take effect from 1 January 2009 although the listing of omeprazole injection is still subject to regulatory approval and further

notification will be advised. Dr Reddy’s Omeprazole will be the only subsidised omeprazole medication available from 1 May 2009 until 30 June 2011.

6 Pharmaceutical Schedule - Update News

Scopoderm TTS

Hyoscine (scopolamine) patches (Scopoderm TTS) are currently partially funded under Special Authority for the control of nausea and vomiting in the treatment of malignancy or chronic disease where the patient cannot take oral antinausea treatments. From 1 January 2009 Scopoderm TTS will be fully subsidised under the existing Special Authority criteria. The Analgesic Subcommittee of PTAC recommended fully funding hyoscine patches under the existing Special Authority criteria, noting that there is no funded equivalent product and that there is a relative lack of fully funded non-oral presentations of antinausea agents.

Levothyroxine stock shortages

Goldshield levothyroxine was listed on 1 November 2008. There have been recent stock shortages as demand for the product has been higher than expected. The recommendation in Medsafe’s letter to prescribers was that the product should be prescribed only for patients experiencing problems with the GSK product (Eltroxin) and/or new patients. It was estimated that Goldshield would receive approximately 20% of the total New Zealand levothyroxine market. This was based on figures derived from reports to CARM, discussions with Medsafe and enquiries to PHARMAC. Information obtained from wholesalers and the supplier (Boucher and Muir) has indicated that approximately 50% of the New Zealand market has subsequently switched to the Goldshield brand of levothyroxine. Higher than expected volumes has meant that stock has been in short supply in recent months. There may be potential shortages in supply over the next five months as it takes time to increase manufacturing and shipping of stock to meet the higher than expected demand. PHARMAC would like to acknowledge the efforts of Goldshield’s supplier Boucher and Muir firstly in bringing stocks to New Zealand so promptly after registration and for their ongoing efforts in keeping the market supplied given that demand has far outstripped estimates. PHARMAC will be working closely with Boucher and Muir to ensure continuity of supply in the future. PHARMAC would also like to thank pharmacists for their support over recent months regarding stock management during the shortage of supply. PHARMAC has had a number of queries regarding listing the Synthroid brand of levothyroxine in the Pharmaceutical Schedule. We are not currently considering any proposals for this brand. It is perhaps timely to reiterate that Medsafe’s provisional consent for Goldshield levothyroxine limits the use of the product to ‘new patients and patients who are intolerant or are unable to take another brand of levothyroxine.’ Compliance with this recommendation by both pharmacists and prescribers will ensure New Zealand stocks remain adequately supplied in the coming months.

Pharmaceutical Schedule - Update News

Changes to the available presentations of diltiazem hydrochloride

Dilzem SR sustained release capsules 90 mg and 120 mg (twice daily) and Dilzem LA long-acting tablets 180 mg and 240 mg (once daily) will be delisted from the Pharmaceutical Schedule from 1 June 2009. The decision to delist these presentations has been made with the intent of simplifying the prescribing and dispensing of diltiazem hydrochloride. The preparations that will remain subsidised will be Dilzem immediate release tablets 30 mg and 60 mg and Cardizem CD long-acting capsules 120 mg, 180 mg and 240 mg (once daily). Extensive consultation and clinical advice regarding which presentations should be available was considered in the decision. Feedback that we have received regarding the appropriate presentations, including consultation feedback indicated that no specific group that will be affected by the decision was unified in its feedback. For example some cardiologists, general practitioners and pharmacists supported the whole proposal, while other cardiologists, general practitioners and pharmacists opposed either parts of the proposal or the whole proposal. Having considered all the views, including positive feedback regarding the proposal from the Cardiovascular Subcommittee of PTAC, it was decided that in the long-term the rationalisation of the funded products was preferable. To assist in the implementation of the patient switch, all the current preparations will remain listed on the Pharmaceutical Schedule fully subsidised until 1 June 2009. PHARMAC will send information to all clinicians and pharmacists providing more detailed advice regarding switching patients in early January. This information and the notification document are available on the PHARMAC website.

tender News

Sole Subsidised Supply changes – effective 1 February 2009

Chemical Name Bicalutamide Polyvinyl alcohol Polyvinyl alcohol Promethazine hydrochloride Promethazine hydrochloride Zopiclone Presentation; Pack size Tab 50 mg Eye drops 1.4% Eye drops 3% Tab 10 mg Tab 25 mg Tab 7.5 mg; 500 tab Sole Subsidised Supply brand (and supplier) Bicalox (Douglas) Vistil (AFT) Vistil Forte (AFT) Allersoothe (AFT) Allersoothe (AFT) Apo-Zoplicone (Apotex)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Possible decisions for implementation 1 february 2009 • Antibiotic oral liquid where diluent must be added – claim for wastage at time of dispensing • Interferon Beta-1-Beta (Betaferon) – listing of new presentation

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Acetazolamide Aciclovir Alprazolam

Presentation

Tab 250 mg; 100 tab Tab dispersible 200 mg Tab dispersible 400 mg Tab 250 µg Tab 500 µg Tab 1 mg Inj 10 mg per ml, 1 ml Cap 100 mg Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Tab 100 mg Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Eye drops 1%; 15 ml OP Inj 600 µg, 1 ml Inj 1200 µg, 1 ml Tab 500 mg Metered aqueous nasal spray 50 µg Metered aqueous nasal spray 100 µg Inj 1 mega u; 10 inj Scalp app 0.1% Tab 200 mg; 90 tab Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Lotion BP Crm, aqueous, BP Inj 100 iu per ml, 1 ml; 5 inj Cap 0.25 µg & 0.5 µg Tab eff 1 g; 30 tab Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 750 mg & 1.5 g

Brand Name Expiry Date*

Diamox Lovir Lovir Arrow-Alprazolam Arrow-Alprazolam Arrow-Alprazolam Mayne Symmetrel Apo-Amoxi Ranbaxy Amoxicillin Ranbaxy Amoxicillin Apo-Ascorbic Acid Ethics Aspirin Ethics Aspirin EC Loten Atropt AstraZeneca AstraZeneca Arrow-Azithromycin Alanase Alanase Sandoz Beta Scalp Fibalip Lax-Tab AFT Marcain Isobaric Marcain Heavy ABM ABM Miacalcic Calcitriol-AFT Calsource Calcium Folinate Ebewe Apo-Captopril Ranbaxy Cefaclor Ranbaxy Cefaclor Zinacef 2011 2009 2010

Apomorphine hydrochloride Amantadine hydrochloride Amoxycillin

2009 2011 2010 2009 2009 2010 2009 2011 2009 2009 2009 2011 2009 2011 2010 2011 2010 2009 2011 2009 2011 2011 2010 2010 2011

Ascorbic acid Aspirin Atenolol Atropine sulphate

Azithromycin Beclomethasone dipropionate Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezafibrate Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine Calcitonin Calcitriol Calcium Calcium folinate Captopril Cefaclor monohydrate Cefuroxime sodium

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Cetomacrogol Chloramphenicol Chlorhexidine gluconate

Presentation

Crm BP Eye drops 0.5% Eye oint 1% Soln 4% Handrub 1% with ethanol 70% Mouthwash 0.2% Tab 25 mg Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Tab 500 µg; 100 tab Tab 2 mg; 100 tab Crm 1% Vaginal crm 1% with applicator(s) Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg Tab 50 mg Cap 25 mg & 50 mg Inj 500 mg Nasal spray 10 mcg per dose Inj 4 mg per ml, 1 ml Inj 4 mg per ml, 2 ml Tab 5 mg Inj 50%, 10 ml Oral soln with electrolytes

Brand Name Expiry Date*

PSM Chlorsig Chlorsig Orion Orion Orion Hygroton Klamycin Klacid Dermol Paxam Paxam Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin Siterone Dantrium Mayne Desmopressin-PH&T Mayne PSM Biomed Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit Voltaren Ophtha Voltaren Voltaren Voltaren Voltaren Voltaren Apo-Diclo Apo-Diclo SR 2010 2009 2011 2009 2009 2010 2009 2011 2011 2010 2010 2010 2010 2010 2010 2009 2010 2009 2009 2010 2011 2009 2010 2011 2010

Chlorthalidone Clarithromycin Clobetasol propionate Clonazepam Clotrimazole Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide Cyproterone acetate Dantrolene sodium Desferrioxamine mesylate Desmopressin Dexamethasone sodium phosphate Dexamphetamine sulphate Dextrose Dextrose with electrolytes

Diclofenac sodium

Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg Suppos 25 mg Suppos 50 mg Suppos 100 mg Tab EC 25 mg & 50 mg Tab long-acting 75 mg & 100 mg

2011

2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Didanosine (DDI) Dipyridamole Doxazosin mesylate Emulsifying ointment Enalapril Ergometrine maleate Ergotamine tartrate with caffeine Erythromycin ethyl succinate

Presentation

Cap 125 mg, 200 mg, 250 mg & 400 mg Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Tab 5 mg, 10 mg & 20 mg Inj 500 µg per ml, 1 ml Tab 1 mg with caffeine 100 mg Grans for oral liq 200 mg per 5 ml; 100 ml Grans for oral liq 400 mg per 5 ml; 100 ml Tab 10 µg Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Cap 50 mg & 100 mg Oral liq 150 mg per 5 ml Tab 5 mg; 30 tab Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 50 mg Cap 150 mg Cap 200 mg Inj 50 mg Tab 10 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Tab 0.8 mg & 5 mg Crm 2% & Oint 2%

Brand Name Expiry Date*

Videx EC Pytazen SR Apo-Doxazosin AFT m-Enalapril Mayne Cafergot E-Mycin E-Mycin New Zealand Medical and Scientific Brevinor 21 Brevinor 1/21 Brevinor 1/28 Vepesid Ferodan Fintral Staphlex AFT AFT Pacific Pacific Pacific Fludara Fludara Ultraproct Ultraproct 2009 2010 2011 2009 2009 2010 2009 2011 2010 2011 2009 2009 2009 2011

Ethinyloestradiol Ethinyloestradiol with norethisterone

Etoposide Ferrous sulphate Finasteride Flucloxacillin sodium

Fluconazole

2011

Fludarabine phosphate Fluocortolone caproate with fluocortolone pivalate and cinchocaine

2011 2010

Fluorometholone Fluoxetine hydrochloride Folic Acid Fusidic acid

Flucon Fluox Fluox Apo-Folic Acid Foban

2009 2010 2009 2010

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

Presentation

Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Oral pump spray 400 µg per dose TDDS 5 mg TDDS 10 mg Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Inj 5 mg per ml, 1 ml Inj 10 iu per ml, 5 ml Crm 1% Tab 5 mg & 20 mg Rectal foam 10%, CFC-Free Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Inj 20 mg, 1 ml Tab 20 mg Oral liq 100 mg per 5 ml, 200 ml Tab 10 mg & 25 mg Tab 2.5 mg Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Inj 50 mg per ml, 2 ml Tab long-acting 60 mg Cap 10 mg Cap 20 mg Cap 100 mg Shampoo 2%, 100 ml OP Oral liq 10 g per 15 ml Eye drops 0.25% & 0.5% Cap 50 mg with benserazide 12.5 mg Tab dispersible 50 mg with benserazide 12.5 mg Cap 100 mg with benserazide 25 mg Cap long-acting 100 mg with benserazide 25 mg Cap 200 mg with benserazide 50 mg

Brand Name Expiry Date*

Pfizer Apo-Gliclazide Minidiab Nitrolingual pumpspray Nitroderm TTS 5 Nitroderm TTS 10 Serenace Serenace Serenace AstraZeneca PSM Douglas Colifoam Locoid DP Lotn HC Buscopan Gastrosoothe Fenpaed Tofranil Napamide Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Duride Isotane 10 Isotane 20 Sporanox Sebizole Duphalac Betagan Madopar 62.5 Madopar Dispersible Madopar 125 Madopar HBS Madopar 250 2009 2011 2011 2011

Haloperidol

2010 2009 2009 2011 2009 2009 2010 2011 2011 2010 2009 2009 2010

Heparinised saline Hydrocortisone Hydrocortisone acetate Hydrcortisone butyrate Hydrocortisone with wool fat and mineral oil Hysocine N-butylbromide Ibuprofen Imipramine hydrochloride Indapamide Ipratropium bromide

Iron polymaltose Isosorbide mononitrate Isotretinoin Itraconazole Ketoconazole Lactulose Levobunolol Levodopa with benserazide

2011 2009 2009 2010 2011 2010 2010 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 12

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Lignocaine hydrochloride

Presentation

Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Ativan Mayne Derbac M A-Lices Ludiomil Colofac Provera Pentasa Arrow-Metformin Methatabs AFT Methotrexate Ebewe Methotrexate Ebewe Methoblastin Prodopa Prodopa Prodopa Rubifen SR Rubifen Rubifen Medrol Advantan Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol 2009 2010 2010 2010

Lignocaine with prilocaine

2010

Lisinopril Loperamide hydrochloride Loratadine

Lorazepam Magnesium sulphate Malathion Maldison Maprotiline hydrochloride Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Metformin hydrochloride Methadone hydrochloride Methotrexate

Tab 1 mg & 2.5 mg Inj 49.3% Liq 0.5% Shampoo 1% Tab 25 mg & 75 mg Tab 135 mg; 90 tab Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Tab 500 mg & 850 mg Tab 5 mg Powder 1 g Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 2.5 mg & 10 mg Tab 125 mg; 100 tab Tab 250 mg; 100 tab Tab 500 mg; 100 tab Tab long-acting 20 mg Tab 5 mg & 20 mg Tab 10 mg Tab 4 mg & 100 mg Crm 0.1% and oint 0.1% Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 1 ml Inj 500 mg & 1 g

2009 2009 2010 2010 2009 2011 2010 2009 2009 2010 2009 2011 2009 2011

Methyldopa

Methylphenidate hydrochloride

2009

Methylprednisolone Methylprednisolone aceponate Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate

2009 2009 2011 2011 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 13

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Metoclopramide hydrochloride Metoprolol tartrate Metyrapone Miconazole nitrate Midodrine Misoprostol Moclobemide Morphine hydrochloride

Presentation

Inj 5 mg per ml, 2 ml Tab long-acting 200 mg Cap 250 mg Crm 2% Tab 2.5 mg & 5 mg Tab 200 µg Tab 150 mg & 300 mg Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Inj 5 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Cap long-acting 10 mg, 30 mg, 60 mg, 100 mg & 200 mg Tab immediate release 10 mg & 20 mg Inj 80 mg per ml, 1.5 ml & 5 ml Tab 40 mg & 80 mg Tab 50 mg Tab 250 mg Tab 500 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 50 mg & 500 mg Tab long-acting 20 mg Tab 5 mg Tab 350 µg Tab 10 mg; 100 tab Tab 25 mg; 250 tab Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u Vaginal crm 100,000 u per 5 g with applicators Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg

Brand Name Expiry Date*

Pfizer Slow-Lopresor Metopirone Multichem Gutron Cytotec Apo-Moclobemide RA-Morph RA-Morph RA-Morph RA-Morph Mayne Mayne Mayne Mayne m-Eslon Sevredol Mayne Apo-Nadolol ReVia Noflam 250 Noflam 500 Sonaflam AstraZeneca Viramune Suspension Apo-Nicotinic Acid Nyefax Retard Primolut N Noriday 28 Norpress Norpress Nilstat Nilstat Nilstat Nilstat Zofran Zofran Zydis 2009 2010 2010 2009 2010 2010 2009 2009 2009 2011 2009 2011 2011 2010 2009 2010 2011 2009 2009 2011 2009 2009 2009 2009

Morphine sulphate

2011 2009

Morphine tartrate Nadolol Naltrexone hydrochloride Naproxen Naproxen sodium Neostigmine Nevirapine Nicotinic acid Nifedipine Norethisterone Nortriptyline hydrochloride Nystatin

Ondansetron

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 14

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Oxybutynin Oxycodone hydrochloride Oxytocin

Presentation

Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml and 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml Tab 20 mg Tab 40 mg

Brand Name Expiry Date*

Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Dr Reddy’s Pantoprazole Dr Reddy’s Pantoprazole Paracare Junior Paracare Double Strength Lacri-Lube Loxamine Permax Permax Pexsig AFT AFT Cilicaine VK Cilicaine VK Prefrin Coloxyl Span-K Apo-Prazo Apo-Prednisone Apo-Prednisone Apo-Prednisone Apo-Prednisone MDS Quick Card Cilicaine Apo-Pyridoxine Accupril 2010 2010 2009

Pamidronate disodium

2011

Pantoprazole

2010

Paracetamol

Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Eye oint with soft white paraffin Tab 20 mg Tab 0.25 mg Tab 1 mg Tab 100 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg Cap potassium salt 500 mg Eye drops 0.12% Oral drops 10%, 30 ml OP Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg; 500 tab Tab 2.5 mg; 500 tab Tab 5 mg; 500 tab Tab 20 mg; 500 tab Cassette Inj 1.5 mega u; 5 inj Tab 50 mg Tab 5 mg; 10 mg & 20 mg

2011

Paraffin liquid with soft white paraffin Paroxetine hydrochloride Pergolide Perhexiline maleate Phenoxymethylpenicillin (Penicillin V)

2010 2010 2011 2009 2010

Phenylephrine hydrochloride Polomaxer Potassium chloride Prazosin hydrochloride Prednisone

2010 2011 2009 2010 2011

Pregnancy tests - HCG urine Procaine penicillin Pyridoxine hydrochloride Quinapril

2009 2011 2009 2011

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 15

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Quinapril with hydroclorothiazide

Presentation

Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 200 mg Tab 300 mg Oral liq 150 mg per 10 ml Cap 150 mg Tab 150 mg & 300 mg Nebuliser soln 1 mg per ml, 2.5 ml Nebuliser soln 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg Tab 5 mg Inj 0.9%, 5 ml & 10 ml Grans eff 4 g sachets Nasal spray 4% Tab 500 mg Tab EC 500 mg Liq Soln 2.3%; 500 ml and 1,000 ml

Brand Name Expiry Date*

Accuretic 10 Accuretic 20 Q 200 Q 300 Peptisoothe Mycobutin Arrow-Roxithromycin Asthalin Asthalin Salapin Duolin Apo-Selegiline AstraZeneca Ural Rex Salazopyrin Salazopyrin EN Midwest Pinetarsol 2009 2010 2010 2009 2009 2010 2009 2009 2009 2010 2009 2009 2010 2011 2011

Quinine sulphate Ranitidine hydrochloride Rifabutin Roxithromycin Salbutamol

Salbutamol with ipratropium bromide Selegiline hydrochloride Sodium chloride Sodium citro-tartrate Sodium cromoglycate Sulphasalazine Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein sodium Temazepam Terbinafine Testosterone cypionate Tetracosactrin Timolol maleate

Tab 10 mg; 25 tab Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 mcg Inj 1 mg per ml, 1 ml Eye drops 0.25% Eye drops 0.5% Tab 10 mg Tab 50 mg Crm 0.02%; 100 g OP Oint 0.02%; 100 g OP Inj 40 mg per ml, 1 ml; 5 inj 0.1% in Dental Paste USP Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 mcg per g Tab 300 mg; 50 tab

Normison Apo-Terbinafine Depo-Testosterone Synacthen Synacthen Depot Apo-Timop Apo-Timop Apo-Timol Apo-Thiamine Aristocort Aristocort Kenacort-A40 Oracort Kenacomb

2011 2011 2011 2011 2011 2009 2009 2011 2011 2009

Thiamine hydrochloride Triamcinolone acetonide

Triamcinolone acetonide with gramicidin, neomycin and nystatin Trimethoprim

TMP

2011

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 16

Sole Subsidised Supply Products – cumulative to January 2009

Generic Name

Ursodeoxycholic acid Vancomycin hydrochloride Vincristine sulphate Vitamins Vitamin B complex Water Zinc and castor oil Zinc sulphate January changes in bold type.

Presentation

Cap 300 mg Inj 50 mg per ml, 10 ml; 1 inj Inj 1 mg per ml, 1 ml Inj 1 mg per ml, 2 ml Tab (BPC cap strength) Tab, strong, BPC Purified for injection 20 ml Ointment BP Cap 220 mg; 100 cap

Brand Name Expiry Date*

Actigall Pacific Mayne Mayne Healtheries Apo-B-Complex Multichem PSM Zincaps 2011 2011 2009 2009 2009 2009 2011 2011

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 17

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 January 2009

109 124 184 ALLOPURINOL ❋ Tab 100 mg .............................................................................. 5.44 ❋ Tab 300 mg .............................................................................. 4.03 (Note: Progout tabs 100 mg and 300 mg to be delisted 1 June 2009) CLOZAPINE – Hospital pharmacy [HP4] Oral liq 50 mg per ml ............................................................... 34.65 250 100 ✔ Apo-Allopurinol ✔ Apo-Allopurinol

100 ml

✔ Clopine

GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital pharmacy [HP3] Italian long style spaghetti .......................................................... 2.00 220 g (3.11)

Orgran

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 January 2009

EXTEMPORANEOUSLY COMPOUNDED PRODUCTS AND GALENICALS Standard Formulae 167 MAGNESIUM HYDROXIDE MIXTURE Magnesium hydroxide paste .................................................. 275 g Methylhydroxybenzoate ............................................................. 1.5 g Water .................................................................................... 770 ml (Not subsidised as a laxative)

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 January 2009

29 OMEPRAZOLE ( subsidy and  price) ❋ Cap 10 mg ................................................................................ 2.14 (8.43) ❋ Cap 20 mg ................................................................................ 3.05 (9.00) ❋ Cap 40 mg ................................................................................ 3.59 (11.25) NIFEDIPINE ( subsidy and price) ❋ Tab long-acting 30 mg ............................................................ 10.70 ❋ Tab long-acting 60 mg ........................................................... 15.35 68 AQUEOUS CREAM ( subsidy) ❋ Crm........................................................................................... 2.28 (2.37) CLOTRIMAZOLE ( subsidy) ❋ Vaginal crm 2% with applicators ................................................ 3.44 (3.99) AMOXYCILLIN ( subsidy) Drops 125 mg per 1.25 ml ........................................................ 2.67 (7.25) Inj 250 mg ................................................................................ 6.21 (6.32) Inj 500 mg ................................................................................ 7.12 (7.32) Inj 1 g ..................................................................................... 10.8 (11.00) 91 CIPROFLOXACIN ( subsidy) Tab 250 mg – Up to 5 tab available on a PSO ............................ 3.13 Tab 500 mg – Up to 5 tab available on a PSO ............................ 4.57 (8.31) Tab 750 mg – Up to 5 tab available on a PSO ............................ 7.04 PYRIDOSTIGMINE BROMIDE ( subsidy) ▲ Tab 60 mg .............................................................................. 40.08 PARACETAMOL ( price) Tab 500 mg - Up to 30 available on a PSO ................................. 1.38 (14.67) 137.81 (1,467.00) 30 Losec 30 Losec 30 Losec 30 30 ✔ Arrow-Nifedipine XR ✔ Adefin XL ✔ Arrow-Nifedipine XR ✔ Adefin XL

500 g Multichem 25 g OP Clotrimaderm 2% 20 ml OP Amoxil Paediatric Drops 5 Ibiamox 5 Ibiamox 5 Ibiamox 28 28 28 28 100 150 Panadol 15,000 Panadol ✔ Cipflox Cipflox ✔ Cipflox

104 111

✔ Mestinon

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 January 2009 (continued)

115 CITALOPRAM HYDROBROMIDE ( subsidy) ❋ Tab 20 mg ................................................................................ 1.26 (3.50) 120 121 124 METOCLOPRAMIDE HYDROCHLORIDE WITH PARACETAMOL ( subsidy) Tab 5 mg with paracetamol 500 mg........................................... 6.77 60 28 ✔ Arrow-Citalopram ✔ Citalopram-Rex Celapram

✔ Paramax

HYOSCINE (SCOPOLAMINE) – Special Authority see SA0727 – Hospital Pharmacy [HP3] ( subsidy) Patches 1.5 mg ....................................................................... 11.95 2 ✔ Scopoderm TTS CLOZAPINE – Hospital pharmacy [HP4] ( subsidy) Tab 25 mg .............................................................................. 13.37 13.37 26.74 Tab 50 mg .............................................................................. 17.33 34.65 Tab 100 mg ............................................................................ 34.65 34.65 69.30 Tab 200 mg ............................................................................ 55.45 110.90 50 50 100 50 100 50 50 100 50 100 ✔ Clopine ✔ Clozaril ✔ Clopine ✔ Clopine ✔ Clopine ✔ Clozaril ✔ Clopine ✔ Clopine ✔ Clopine ✔ Clopine

136

OXALIPLATIN – PCT only – Specialist – Special Authority see SA0900 ( subsidy and price) Inj 50 mg .............................................................................. 200.00 1 ✔ Eloxatin Inj 100 mg ............................................................................ 400.00 1 ✔ Eloxatin Inj 1 mg for ECP ........................................................................ 4.36 1 mg ✔ Baxter OCTREOTIDE (SOMATOSTATIN ANALOGUE) - Special Authority see SA0563 – Hospital pharmacy [HP3] ( subsidy) Inj 50 µg per ml,1 ml .............................................................. 25.65 (43.50) Inj 100 µg per ml, 1 ml ........................................................... 48.50 (81.00) Inj 500 µg per ml, 1 ml .......................................................... 175.00 (399.00) HYPROMELLOSE ( subsidy) ❋ Eye drops 0.5% ........................................................................ 2.00

146

5 Sandostatin 5 Sandostatin 5 Sandostatin

161 184

15 ml OP

✔ Methopt

GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital Pharmacy [HP3] Buckwheat Spirals ..................................................................... 2.00 250 g OP (3.11) Corn and Spinach Rigattini......................................................... 2.00 250 g OP (2.92) Corn and Vegetable Shells ......................................................... 2.00 250 g OP (2.92) Corn and Vegetable Spirals ........................................................ 2.00 250 g OP (2.92) Garlic and Parsley Shells ........................................................... 2.00 250 g OP (2.92)

Orgran Orgran Orgran Orgran Orgran continued...

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 January 2009 (continued)

continued... Rice and Corn Garden Herb Pasta .............................................. 2.00 (2.92) Rice and Corn Lasagne Sheets .................................................. 2.00 (3.82) Rice and Corn Macaroni ............................................................ 2.00 (2.92) Rice and Corn Penne ................................................................. 2.00 (2.92) Rice and Maize Pasta Spirals ..................................................... 2.00 (2.92) Rice and Millet Spirals ............................................................... 2.00 (3.11) Rice and corn spaghetti noodles ................................................ 2.00 (2.92) Vegetable and Rice Spirals......................................................... 2.00 (2.92) 250 g OP Orgran 200 g OP Orgran 250 g OP Orgran 250 g OP Orgran 250 g OP Orgran 250 g OP Orgran 375 g OP Orgran 250 g OP Orgran

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Description

Effective 1 January 2009

38 CALCIUM Tab eff 1 g (elemental) ............................................................. 6.54 30 ✔ Calsource

Changes to Sole Subsidised Supply

Effective 1 January 2009

For the list of new Sole Subsidised Supply products effective 1 January 2009 refer to the bold entries in the cumulative Sole Subsidised Supply table pages xx-xx.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 January 2009

29 115 184 OMEPRAZOLE ❋ Cap 10 mg ................................................................................ 2.14 (5.95) ❋ Cap 20 mg ................................................................................ 3.05 (5.95) ❋ Cap 40 mg ................................................................................ 3.59 (8.84) NORTRIPTYLINE HYDROCHLORIDE Tab 25 mg .............................................................................. 34.90 30 Omezol 30 Omezol 30 Omezol 500

✔ Norpress

GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital Pharmacy [HP3] Garlic and Parsley spirals .......................................................... 2.00 250 g (2.63)

Orgran

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 February 2009

161 POLYVINYL ALCOHOL ❋ Eye drops 1.4 % ........................................................................ 2.68 ❋ Eye drops 3% ............................................................................ 3.75 15 ml OP 15 ml OP ✔ Liquifilm Tears ✔ Liquifilm Forte

Effective 1 March 2009

59 91 VERAPAMIL HYDROCHLORIDE ❋ Tab 40 mg ................................................................................ 4.75 FLUCLOXACILLIN SODIUM Inj 250 mg ............................................................................... 4.66 Inj 500 mg ................................................................................ 5.45 100 5 5 ✔ Verpamil ✔ Flucloxin ✔ Flucloxin

Effective 1 April 2009

90 AMOXYCILLIN Drops 125 mg per 1.25 ml ........................................................ 2.67 (7.25) Inj 250 mg ............................................................................... 6.21 (6.32) Inj 500 mg ................................................................................ 7.12 (7.23) Inj 1 g – Up to 5 inj available ona PSO...................................... 10.81 (11.00) 115 CITALOPRAM HYDROBROMIDE ( subsidy) ❋ Tab 20 mg ................................................................................ 1.26 (3.50) 146 20 ml OP Amoxil Paediatric Drops 5 Ibiamox 5 Ibiamox 5 Ibiamox 28

✔ Arrow-Citalopram ✔ Citalopram-Rex Celapram

OCTREOTIDE (SOMATOSTATIN ANALOGUE) – Special Authority see SA0563 – Hospital Pharmacy [HP3] Inj 50 µg per ml, 1 ml ............................................................. 25.65 5 (43.50) Sandostatin Inj 100 µg per ml, 1 ml ............................................................ 48.50 5 (81.00) Sandostatin Inj 500 µg per ml, 1 ml .......................................................... 175.00 5 (399.00 Sandostatin PHENYL FREE PASTA – Special Authority see SA0733 – Hospital pharmacy [HP3] Macaroni ................................................................................. 10.65 500 g OP (11.91)

186

Loprofin

Effective 1 May 2009

53 DOXAZOSIN MESYLATE ❋ Tab 2 mg ................................................................................. 4.81 Note – the 500 tablet pack listed 1 November 2008 100 ✔ Apo-Doxazosin

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 May 2009 (continued)

81 OESTRADIOL VALERATE – See prescribing guideline ❋ Tab 2 mg ................................................................................. 4.12 28 ✔ Progynova

Effective 1 June 2009

53 DOXAZOSIN MESYLATE ❋ Tab 4 mg .................................................................................. 6.37 Note – the 500 tablet pack listed 1 December 2008 CARBAMAZEPINE ❋ Tab 200 mg ........................................................................ 29.06 Note – the 100 tablet pack size listed 1 December 2008 100 ✔ Apo-Doxazosin

116

200

✔ Tegretol

Effective 1 July 2009

48 WATER 1) on a prescription or Practitioner’s Supply order only when on the same form as an injection listed in the Pharmaceutical Schedule requiring a solvent or diluent; or 2) on a bulk supply order; or 3) When used in the extemporaneous compounding of eye drops Purified for inj 2 ml – Up to 5 ink available on a PSO ................ 21.90 50 ✔ Baxter CROTAMITON a) Only on a prescription b) Not in combination Lotn 10% .................................................................................. 7.56 (7.70) FLUOROURACIL SODIUM Inj 500 mg per ml, 20 ml – PCT only – Specialist ..................... 55.60

50 ml Eurax 10 ✔ Mayne

137 177

PAEDIATRIC ORAL FEED 1.5KCAL/ML –Special Authority see SA0986 – Hospital pharmacy [HP3] Liquid (chocolate) ..................................................................... 1.27 200 ml OP ✔ Resource Just for Kids Liquid (vanilla)........................................................................... 1.27 200 ml OP ✔ Resource Just for Kids GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital pharmacy [HP3] Corn and Parsley fettucine ......................................................... 2.00 250 g OP (2.63)

184

Orgran

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 January 2009

ALLOPURINOL (new listing and HSS) Tab 100 mg ...................................Apo-Allopurinol Tab 300 mg....................................Apo-Allopurinol 5.44 4.03 250 100 1% 1% Mar-09 Mar-09 Allohexal Allorin Progout Allohexal Allorin Progout

(Note: Progout 100 mg and 300 mg to be delisted 1 March 2009) CLOZAPINE (new listing) Oral liq 50 mg per ml .....................Clopine CLOZAPINE ( price) Tab 25 mg......................................Clozaril Clopine Clopine Tab 50 mg......................................Clopine Clopine Tab 100 mg....................................Clozaril Clopine Clopine Tab 200 mg....................................Clopine Clopine HYOSCINE (SCOPOLAMINE) (new listing) Patches 1.5 mg .............................Scopoderm TTS HYPROMELLOSE (new listing and HSS) Eye drops 0.5% ..............................Methopt 45.60 13.37 26.74 17.33 34.65 34.65 69.30 55.45 110.90 11.95 2.00 100 ml 50 100 50 100 50 100 50 100 2 15 ml 1% Mar-09 (B)

NIFEDIPINE ( price) Tab long-acting 30 mg....................Arrow-Nifedipine XR10.70 Adefin XL Tab long-acting 60 mg....................Arrow-Nifedipine XR15.35 Adefin XL OMEPRAZOLE (new listing) Inf 40 mg ......................................Dr Reddy’s Omeprazole 38.65

30 30

OMEPRAZOLE ( price) Cap 10 mg .....................................Losec 8.43 30 Cap 20 mg .....................................Losec 9.00 30 Cap 40 mg .....................................Losec 11.25 30 (Note: Losec 10 mg, 20 mg and 40 mg to be delisted 1 May 2009) OXALIPLATIN ( price) Inj 50 mg........................................Eloxatin Inj 100 mg......................................Eloxatin Products with Hospital Supply Status (HSS) are in bold. 200.00 400.00 1 1 (B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II – effective 1 December 2008

ADRENALINE (new listing) Inj 1,000, 1 ml ................................Aspen-Adrenaline AMISULPRIDE (new listing) Tab 100 mg....................................Solian Tab 200 mg....................................Solian Tab 400 mg....................................Solian Oral liquid 100 mg per ml ...............Solian AMLODIPINE (new listing) Tab 5 mg........................................Apo-Amlodipine 4.98 22.52 97.03 185.44 55.44 7.33 5 30 60 60 60 ml 100 100 1% 1% Feb-09 Feb-09 Calvasc Norvasc Calvasc Norvasc

Tab 10 mg......................................Apo-Amlodipine 11.79 ANASTROZOLE-DP (new listing) Tab 1 mg........................................DP-Anastrozole CEFAZOLIN SODIUM (delisting) Inj 500 mg......................................m-Cefazolin Inj 1 g.............................................m-Cefazolin CETIRIZINE HYDROCHLORIDE (new listing) Tab 10 mg......................................Zetop

29.50 13.60 18.60 2.21

30 10 10 100 1% Feb-09 Apo-Cetirizine Allerid-C Cetirizine Histaclear Razene Allerid-C Zyrtec

Oral Liquid 1 mg per 1 ml ..............Cetirizine-AFT Note – Allerid-C to be delisted 1 Feb 2009 DILTIAZEM HYDROCHLORIDE (new listing) Tab 30 mg......................................Dilzem Tab 60 mg......................................Dilzem Cap long-acting 120 mg .................Cardizem CD Cap long-acting 180 mg .................Cardizem CD Cap long-acting 240 mg .................Cardizem CD

3.50

200 ml

Feb-09

4.50 8.50 4.72 7.08 9.44

100 100 30 30 30

5% 5% 5% 5% 5% 1%

Jun-09 Jun-09 Jun-09 Jun-09 Jun-09 Jan-09

(B) (B) (B) Dilzem LA Dilzem LA Dosan

DOXAZOSIN MESYLATE (new listing) Tab 4 mg........................................Apo-Doxazosin 30.26 500 Note – Apo-Doxazosin tab 4 mg 100 tablet pack size to be delisted 1 Feb 2009 FLUOROURACIL SODIUM (new listing) Crm 5% ..........................................Efudix POTASSIUM CHLORIDE (delisting) Inj 75 mg per ml, 10 ml ..................AstraZeneca Inj 150 mg per ml, 10 ml ................AstraZeneca 26.49 26.00 26.00 20 g 50 50

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Chemical and presentation

Brand

Section H changes to Part IV

Effective 1 December 2008

SPECIAL FOOD SUPPLEMENT Liquid, 237 ml Impact Advanced Recovery Vanilla and Chocolate Three packs of 237 mls per days for 5 to 7 days prior to major gastrointestinal or head or neck surgery.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands A Adefin XL ..................................................... 20, 27 Adrenaline.......................................................... 28 Allopurinol.................................................... 18, 27 Amisulpride........................................................ 28 Amlodipine......................................................... 28 Amoxil Paediatric Drops ............................... 20, 25 Amoxycillin .................................................. 20, 25 Anastrozole-dp ................................................... 28 Apo-Allopurinol ............................................ 18, 27 Apo-Amlodipine ................................................. 28 Apo-Doxazosin....................................... 25, 26, 28 Aqueous cream .................................................. 20 Arrow-Citalopram ......................................... 21, 25 Arrow-Nifedipine XR ..................................... 20, 27 Aspen-Adrenaline ............................................... 28 C Calcium ............................................................. 23 Calsource .......................................................... 23 Carbamazepine .................................................. 26 Cardizem CD ...................................................... 28 Cefazolin sodium ............................................... 28 Celapram ..................................................... 21, 25 Cetirizine-AFT..................................................... 28 Cetirizine hydrochloride ...................................... 28 Cipflox ............................................................... 20 Ciprofloxacin ...................................................... 20 Citalopram hydrobromide ............................. 20, 25 Citalopram-Rex ............................................ 21, 25 Clopine .................................................. 18, 21, 27 Clotrimaderm 2% ............................................... 20 Clotrimazole ....................................................... 20 Clozapine ............................................... 18, 21, 27 Clozaril ........................................................ 21, 27 Crotamiton ......................................................... 26 D Diltiazem hydrochloride ...................................... 28 Dilzem ............................................................... 28 DP-Anastrozole .................................................. 28 Dr Reddy’s Omeprazole...................................... 27 Doxazosin mesylate ............................... 25, 26, 28 E Efudix ................................................................ 28 Eloxatin ........................................................ 21, 27 Eurax ................................................................. 26 F Flucloxacillin sodium .......................................... 25 Flucloxin ............................................................ 25 Fluorouracil sodium...................................... 26, 28 G Gluten free pasta .............................. 18, 21, 24, 26 H Hyoscine (scopolamine)............................... 21, 27 Hypromellose............................................... 21, 27 I Impact Advanced Recovery Vanilla and Chocolate 29 Ibiamox........................................................ 20, 25 L Liquifilm Forte .................................................... 25 Liquifilm Tears ................................................... 25 Loprofin ............................................................. 25 Losec .......................................................... 20, 27 M m-Cefazolin ....................................................... 28 Methopt ....................................................... 21, 27 Metoclopramide hydrochloride with paracetamol 20 Magnesium hydroxide mixture ............................ 19 Mestinon............................................................ 20 N Nifedipine..................................................... 20, 27 Norpress ............................................................ 24 Nortriptyline hydrochloride.................................. 24 O Octreotide (somatostatin analogue) .............. 21, 25 Oestradiol valerate.............................................. 26 Omeprazole............................................ 20, 24, 27 Omezol .............................................................. 24 Orgran ....................................... 18, 21, 22, 24, 26 Oxaliplatin .................................................... 21, 27 P Paediatric oral feed 1.5kcal/ml............................ 26 Panadol ............................................................. 20 Paramax ............................................................ 21 Phenyl free pasta ............................................... 25 Polyvinyl alcohol ................................................ 25 Potassium chloride ............................................ 28 Progynova ......................................................... 26 Pyridostigmine bromide...................................... 20 R Resource Just for Kids ....................................... 26 S Sandostatin .................................................. 21, 25 Scopoderm TTS ........................................... 21, 27 Solian ................................................................ 28 Special food supplement .................................... 29 T Tegretol ............................................................. 26 V Verapamil hydrochloride ..................................... 25 Verpamil ............................................................ 25 W Water ................................................................. 26 Z Zetop ................................................................. 28

Pharmaceutical Management Agency Level 9, Cigna House, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

Metadata

Title

Schedule Update - effective 1 January 2009

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January 2009 Section H cumulative for December 2008 and January 2009 Contents Summary of PHARMAC decisions effective 1 January 2009 … 3 Named Specialists for antiretrovirals …. 4 Panadol –…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.